In a 125-patient real-world HCC analysis using a tumour-informed assay, serial ctDNA monitoring detected recurrence earlier than AFP, with a median lead time ~7.9 months in subcohorts (post-resection and post-LT) and clear prognostic separation by ctDNA status [74]. Here, AFP is linked to hepatocellular carcinoma.